Skip to main content
. 2020 Jul 30;10:12826. doi: 10.1038/s41598-020-69785-3

Table 1.

Maternal baseline characteristics and pregnancy outcomes according to time period.

Period 1 (n = 220) Period 2 (n = 227) Period 3 (n = 188) P value
Age (years) 33.3 ± 3.9 33.3 ± 3.9 33.6 ± 3.8 0.751
Body mass index (kg/m2) 25.1 ± 4.1 25.1 ± 4.0 25.7 ± 4.0 0.243
Multiparity 90 (40.9) 79 (34.8) 60 (31.9) 0.150
Plurality 0.0011
Singleton 168 (76.4) 193 (85.0) 150 (79.8)
Twin 51 (23.2) 34 (15.0) 31 (16.5)
Triplet 1 (0.5) 0 (0) 7 (3.7)
Antenatal MgSO4 exposure 46 (20.9) 141 (62.1) 28 (14.9)  < 0.00112
Dose of MgSO4 54.0 ± 62.6 16.4 ± 47.1 63.1 ± 53.1  < 0.00112
Indication of MgSO4 exposure  < 0.00112
Neuroprotection 1 (2.2) 108 (76.6) 0 (0)
Severe preeclampsia 30 (65.2) 29 (20.6) 25 (89.3)
Tocolysis 15 (32.6) 4 (2.8) 3 (10.7)
Antenatal corticosteroids exposure 196 (89.1) 202 (89.0) 179 (95.2) 0.048123
Cycle of corticosteroids 0.372
Incomplete course 47 (24.0) 37 (18.3) 32 (17.9)
Complete course 111 (56.6) 132 (65.3) 116 (64.8)
Rescue course 38 (19.4) 33 (16.3) 31 (17.3)
Tocolysis
Ritodrine 121 (55.0) 100 (44.1) 91 (48.4) 0.067
Atosiban 85 (38.6) 77 (33.9) 64 (34.0) 0.506
Nifedipine 74 (33.6) 54 (23.8) 39 (20.7) 0.0073
Indication of delivery 0.268
PTL 97 (44.1) 88 (38.8) 63 (33.5)
PPROM 64 (29.1) 77 (33.9) 65 (34.6)
Maternal–fetal indication 59 (26.8) 62 (27.3) 60 (31.9)
Cesarean delivery 165 (75.0) 166 (73.1) 135 (71.8) 0.763
Histologic chorioamnionitis 102 (46.4) 107 (47.1) 87 (46.3) 0.981

Data are presented as number (percentage) or mean ± standard deviation.

MgSO4 magnesium sulfate, PTL preterm labor, PPROM preterm premature rupture of membrane.

1Significantly different between period 2 and period 3 (Bonferroni test).

2Significantly different between period 1 and period 2 (Bonferroni test).

3Significantly different between period 1 and period 3 (Bonferroni test).